Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

TLRY - Tilray Inc Stock Price, Fair Value and News

$1.20-0.01 (-0.83%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

TLRY Price Action

Last 7 days

9.8%

Last 30 days

16.0%

Last 90 days

241.7%

Trailing 12 Months

-30.9%

TLRY RSI Chart

2025FebMarAprMayJunJulAugSep0102030405060708090

TLRY Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-0.6

Price/Sales (Trailing)

1.61

EV/EBITDA

-0.51

Price/Free Cashflow

-13.96

TLRY Price/Sales (Trailing)

20232024202501234567

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TLRY Fundamentals

TLRY Revenue

Revenue (TTM)

821.3M

Rev. Growth (Yr)

-2.33%

Rev. Growth (Qtr)

20.86%

20182020202220240200M400M600M800M

TLRY Earnings

Earnings (TTM)

-2.2B

Earnings Growth (Yr)

-3.9K%

Earnings Growth (Qtr)

-61.23%

2018202020222024-2B-1.5B-1B-500M0

TLRY Profitability

Operating Margin

87.95%

EBT Margin

-280.33%

Return on Equity

-144.68%

Return on Assets

-105.42%

Free Cashflow Yield

-7.16%

TLRY Investor Care

Shares Dilution (1Y)

30.56%

Diluted EPS (TTM)

-2.43

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
2017201820192020202120222023202420250100M200M300M400M500M600M700M800M900M
Net sales
YearQ1Q2Q3Q4
2025826.7M821.3M00
2024743.2M788.9M812.0M829.2M
2023596.3M627.1M650.9M700.5M
2022617.3M628.4M613.6M602.5M
2021361.3M370.7M482.2M513.4M
2020295.7M320.3M333.5M348.8M
201958.4M179.3M293.7M281.1M
201823.3M28.1M32.7M43.1M
201714.6M16.6M18.6M20.5M
201600012.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Tilray Inc

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
 CEO
 WEBSITEtilray.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES1600

Tilray Inc Frequently Asked Questions

What is the ticker symbol for Tilray Inc? What does TLRY stand for in stocks?

TLRY is the stock ticker symbol of Tilray Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tilray Inc (TLRY)?

As of Fri Sep 19 2025, market cap of Tilray Inc is 1.35 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TLRY stock?

You can check TLRY's fair value in chart for subscribers.

Is Tilray Inc a good stock to buy?

The fair value guage provides a quick view whether TLRY is over valued or under valued. Whether Tilray Inc is cheap or expensive depends on the assumptions which impact Tilray Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TLRY.

What is Tilray Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Sep 19 2025, TLRY's PE ratio (Price to Earnings) is -0.62 and Price to Sales (PS) ratio is 1.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TLRY PE ratio will change depending on the future growth rate expectations of investors.